It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Why inflammation is common in ileal pouches with ulcerative colitis (UC) is unclear. We therefore clarified the morphological changes in pouches and afferent limbs (AL) of patients with UC and explored the relationship between these findings. We evaluated the morphological findings (histological and endoscopic inflammation as the Pouchitis Disease Activity Index [PDAI] histology subscore [hPDAI] and endoscopy subscore [ePDAI], inflammatory bowel disease [IBD]-specific findings using the IBD score [SIBD], colonic metaplasia using the colonic metaplasia score [CMS], and goblet cell [GC] ratio) in the pouch and AL of patients with UC. A total of 261 pouchoscopies were analyzed. The pouch body had a higher hPDAI (p < 0.001), SIBD (p < 0.001), CMS (p < 0.001), GC ratio (p < 0.001), and ePDAI (p < 0.001) than the AL. The hPDAI was correlated with the SIBD (Spearman’s coefficient r = 0.538; p < 0.001), CMS (r = 0.687; p < 0.001), and the ePDAI (r = 0.552; p < 0.001), but not with GC ratio (r = 0.175; p < 0.001) or the pouch usage duration (r = −0.057; p = 0.107). The incidence of histological inflammation was higher in specimens showing basal plasmacytosis with severe mononuclear cell infiltration (BP) than in those without BP (odds ratio [OR] 6.790, p < 0.001), BP was commonly found with crypt hyperplasia (OR 3.414, p < 0.001) and the crypt length correlated with neutrophil infiltration (r = 0.469; p < 0.001). Histological inflammation, colonic metaplasia, the GC ratio, endoscopic inflammation, and IBD-specific findings were commonly present in the pouch than in the AL. Histological inflammation occurs with IBD-specific findings and colonic metaplasia, and these signify endoscopic inflammation.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Yokohama City University Graduate School of Medicine, Department of Gastroenterological Surgery, Yokohama, Japan (GRID:grid.268441.d) (ISNI:0000 0001 1033 6139); Yokohama City University Medical Center, Inflammatory Bowel Disease Center, Yokohama, Japan (GRID:grid.413045.7) (ISNI:0000 0004 0467 212X)
2 Yokohama City University Medical Center, Inflammatory Bowel Disease Center, Yokohama, Japan (GRID:grid.413045.7) (ISNI:0000 0004 0467 212X)
3 Yokohama City University Medical Center, Diagnostic Pathology, Yokohama, Japan (GRID:grid.413045.7) (ISNI:0000 0004 0467 212X)
4 Yokohama City University Graduate School of Medicine, Department of Gastroenterological Surgery, Yokohama, Japan (GRID:grid.268441.d) (ISNI:0000 0001 1033 6139)
5 Yokohama City University Medical Center, Department of Surgery, Gastroenterological Center, Yokohama, Japan (GRID:grid.413045.7) (ISNI:0000 0004 0467 212X)
6 Yokohama City University School of Medicine, Department of Biostatistics, Yokohama, Japan (GRID:grid.268441.d) (ISNI:0000 0001 1033 6139)